ADIL Adial Pharmaceuticals
- 1.7000
- +0.0100+0.59%
Adial Pharmaceuticals News
Adial Pharmaceuticals Finalizes Separation Agreement With Dr. Johnson
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder
Adial Pharmaceuticals (ADIL) said Monday it has been granted a US patent covering the combination of its proprietary genetic diagnostic and its lead Investigational New Drug AD04 to treat alcohol use
Express News | Adial Pharmaceuticals Granted Key Patent From the United States Patent and Trademark Office
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersAdial Pharmaceuticals (NASDAQ:ADIL) stock rose 34.2% to $2.59 during Monday's pre-market session. The company's market cap stands at $10.5 million. NKGen Biotech (NASDAQ:NKGN) shares moved upwa
EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent
On April 16, 2024, the United States Patent and Trademark Office issued patent number 11957664 to Adial Pharmaceuticals Inc (NASDAQ:ADIL). This patent expands Adial's intellectual property protection
Express News | EXCLUSIVE: Adial Therapeutics Tells Benzinga 'This Patent Expands Adial's Intellectual Property Protection and Covers the Combination of the Company's Proprietary Genetic Diagnostic to Identify Patients With Specific Genotypes
Express News | EXCLUSIVE: Adial Therapeutics Tells Benzinga Co. Granted Key Patent From The United States Patent And Trademark Office
Express News | Adial Pharmaceuticals Inc Files for Common Stock Offering of up to $4.3 Mln - SEC Filing
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersINVO Bioscience (NASDAQ:INVO) stock rose 275.0% to $2.85 during Wednesday's regular session. The market value of their outstanding shares is at $7.4 million. As per the news, the Q4 earnings re
Adial Pharmaceuticals Announces CMO's Departure and Leadership Changes
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals Among Healthcare Movers
Express News | Adial Pharmaceuticals Files Prospectus Relates To Resale From Time To Time Of Up To 2.36M Shares Of Common Stock By Selling Stockholders
Express News | Adial Pharmaceuticals- Files Prospectus Relates to Resale From Time to Time of up to 2.36 Mln Shares of Common Stock by Selling Stockholders
Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersPaxMedica (NASDAQ:PXMD) stock moved upwards by 104.2% to $0.84 during Friday's pre-market session. The market value of their outstanding shares is at $6.2 million. Allarity Therapeutics (NASDAQ
Top Premarket Decliners
Monogram Orthopaedics (MGRM) shares were down more than 15% in recent Friday premarket activity, paring Thursday's rally. Rallybio Corp. (RLYB) stock was 12% lower, reversing from Thursday's rally. Ad
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of NextPlat Corp (NASDAQ:NXPL) rose sharply in today's pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year NextPlat shares surged
Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)
Analysis
Price Target
No Data
